undamentalytics Newsletter
Sign in

Volitionrx LTD cash flow statement

In fiscal 2025, Volitionrx LTD's operations generated −$19.7m of cash; it spent $89,558 on capital projects, leaving free cash flow of −$19.8m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20112012Dec 20122014Dec 20142019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−2−2−4−13−16−21−15−18−26−20−20
Depreciation and amortisation00011111111
Stock-based pay01111232121
Capital spending00012121000
Free cash flow−2−2−4−13−18−22−17−19−26−20−20
Free cash flow after stock pay−2−3−5−15−20−24−20−21−27−22−21
Share buybacks——————000——
Shares issued23617212372891119

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: FEMY vs VNRXICCM vs VNRXICU vs VNRX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Volitionrx LTD's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Volitionrx LTD.